Steimnitz Jules MD - 94110 San Francisco, CA

Business Name: Steimnitz Jules MD
Categorized In: Doctors
Address: 1580 Valencia St # 210, San Francisco, CA 94110
Phone Number: (415) 641-8631
Contact Person: Jules Steimnitz
Website Address: jps.yourmd.com
NAICS Code: 6211110
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Founding Year: 1988
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $500.000 to $999.999
Share This Business:
Similar Businesses: Schneider Heidi M MD - San Francisco, CA 94110
Knudson Peggy MD - San Francisco, CA 94110
Mankani Masesh MD - San Francisco, CA 94110
Lee Chen MD - San Francisco, CA 94110
Welch William MD - San Francisco, CA 94110
Campbell Andre MD - San Francisco, CA 94110
Mentzer William C MD - San Francisco, CA 94110
Liskey Lee MD - San Francisco, CA 94110
Labovitch Ryan MD - San Francisco, CA 94110
Matityahu Amir M MD - San Francisco, CA 94110
Romero-Duran Adolfo MD - San Francisco, CA 94110
Skarbinski Jack MD - San Francisco, CA 94110
Darney Philip D MD - San Francisco, CA 94110
Kim Ann MD - San Francisco, CA 94110
Lee Theodore J MD - San Francisco, CA 94110
Buckley Robert MD - San Francisco, CA 94110
Mc Clellan Robert T MD - San Francisco, CA 94110
Rodriguez Robert M MD - San Francisco, CA 94110
Hill Arthur MD - San Francisco, CA 94110
Mac Kersie Robert C MD - San Francisco, CA 94110

Steimnitz Jules MD provides professional Doctors from its single location at the coordinates 37.747192,-122.42025.

The company offers B2C variables under the SIC code 8011 and NAICS code 6211110, while making an annual revenue of $500.000 to $999.999 and hiring a total of 1 to 4 employees.

Founded in 1988, the company can now be visited at 1580 Valencia St # 210, San Francisco, California 94110 or contacted through representative Jules Steimnitz at (415) 641-8631.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Steimnitz Jules MD through its company website at jps.yourmd.com. Engage with this business on its social media platforms through on Twitter and on Facebook.